Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)James R. Berenson, Robert Vescio, Noemi Silagan et al.|Blood|2020Cited by 2
A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)James R. Berenson, Robert Vescio, A.J. Munayco Sánchez et al.|Blood|2019Cited by 2